National Mesothelioma Virtual Bank — patient biosamples and data network
Continuation and Expansion of the National Mesothelioma Virtual Bank for Translational Research (U24) - 2021
['FUNDING_OTHER'] · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · NIH-11121710
Collects and shares tissue, blood, and medical information from people with mesothelioma to help researchers develop better tests and treatments.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF PITTSBURGH AT PITTSBURGH (nih funded) |
| Locations | 1 site (PITTSBURGH, UNITED STATES) |
| Trial ID | NIH-11121710 on ClinicalTrials.gov |
What this research studies
If I join, the NMVB asks me to donate tissue and blood and to share my medical records, job history, and imaging so researchers can study mesothelioma. The program links those samples with protein, genomic, and imaging data and is coordinated by the University of Pittsburgh with partner hospitals. They plan to expand the bank to about 2,200 patients and add Baylor College of Medicine to increase geographic and racial diversity. The team is also working to speed and standardize data entry by extracting clinical and pathology details from electronic health records.
Who could benefit from this research
Good fit: Adults diagnosed with mesothelioma who are willing to donate blood or tissue and share clinical and occupational history at one of the participating centers.
Not a fit: People without mesothelioma or those unwilling or unable to provide samples or medical records would not directly participate or receive personal medical benefit from this biobank.
Why it matters
Potential benefit: Could help researchers find new biomarkers and treatments more quickly and make studies more relevant to people like you.
How similar studies have performed: Other cancer biobanks have successfully supported biomarker discovery and treatment research, and this effort expands the existing NMVB network.
Where this research is happening
PITTSBURGH, UNITED STATES
- UNIVERSITY OF PITTSBURGH AT PITTSBURGH — PITTSBURGH, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: BECICH, MICHAEL JOHN — UNIVERSITY OF PITTSBURGH AT PITTSBURGH
- Study coordinator: BECICH, MICHAEL JOHN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.